KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Long-Term Deferred Tax: 2010-2024

Historic Long-Term Deferred Tax for Charles River Laboratories International (CRL) over the last 15 years, with Dec 2024 value amounting to $42.2 million.

  • Charles River Laboratories International's Long-Term Deferred Tax fell 2.78% to $36.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.9 million, marking a year-over-year decrease of 2.78%. This contributed to the annual value of $42.2 million for FY2024, which is 4.72% up from last year.
  • According to the latest figures from FY2024, Charles River Laboratories International's Long-Term Deferred Tax is $42.2 million, which was up 4.72% from $40.3 million recorded in FY2023.
  • Over the past 5 years, Charles River Laboratories International's Long-Term Deferred Tax peaked at $42.2 million during FY2024, and registered a low of $37.7 million during FY2020.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $41.3 million (2022), whereas its average is $41.2 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Long-Term Deferred Tax fell by 15.52% in 2020, and later increased by 6.62% in 2021.
  • Charles River Laboratories International's Long-Term Deferred Tax (Yearly) stood at $37.7 million in 2020, then rose by 6.62% to $40.2 million in 2021, then increased by 2.58% to $41.3 million in 2022, then dropped by 2.38% to $40.3 million in 2023, then rose by 4.72% to $42.2 million in 2024.